| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/11/2007 | EP1318142B1 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP1025521B1 Computer method utilizing free energy calculations for ligand design and the prediction of binding targets |
| 04/11/2007 | EP1012191B1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 04/11/2007 | EP1005492B1 Purification of von willebrand factor by cation exchanger chromatography |
| 04/11/2007 | CN1946739A Purified interleukin-15/fc fusion protein and preparation thereof |
| 04/11/2007 | CN1946738A Animal product free system and process for purifying a botulinum toxin |
| 04/11/2007 | CN1946290A Modified serum albumin with reduced affinity for nickel and copper |
| 04/11/2007 | CN1944456A Process for preparing duck wheat anti-tumor protein |
| 04/11/2007 | CN1943560A Sandwich structure magnetic composite micro ball with functional shell layer, its preparing method and use |
| 04/10/2007 | US7202349 Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof |
| 04/10/2007 | US7202345 PRO 1384 antibodies |
| 04/10/2007 | US7202332 Methods for preparing internally constrained peptides and peptidomimetics |
| 04/10/2007 | US7202207 Infection therapy; binding of mannan lecithin to protein |
| 04/10/2007 | US7202093 Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds |
| 04/10/2007 | US7202077 Comprises nucleotide sequences for use as gene transfer tools; plasmids; expression vectors |
| 04/10/2007 | US7202075 Isolated protein having hydroxynitrile lyase activity |
| 04/10/2007 | US7202061 fermentaion of amino acids for use in human medicine, foods and animal nutrients; fermenting modified coryneform bacterium; modifiied by reducing or eliminating the intracellular activity of MikE17 in said cell relative to the activity of MikE17 in an unmodified bacterium of the same strain |
| 04/10/2007 | US7202058 IGF-1 receptor interacting proteins |
| 04/10/2007 | US7202050 Measuring protein kinase or phosphatase activity in a sample with a reporter peptide, or a fluorescently-labeled phosphorylatable reporter peptide, cleaved by a protease, without using antibodies or radioactive labels |
| 04/10/2007 | US7201903 Method and device for detecting feline immunodeficiency virus |
| 04/10/2007 | US7201901 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration |
| 04/10/2007 | US7201897 Interferon conjugates |
| 04/10/2007 | US7201895 High-affinity antagonists of ELR-CXC chemokines |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/10/2007 | CA2102447C Cyclopeptides |
| 04/05/2007 | WO2006110292A3 Temperature-triggered immobilization and purification of antibodies |
| 04/05/2007 | WO2006086428A3 Particles for inactivating toxins |
| 04/05/2007 | WO2006056443A3 Method for solid-phase peptide synthesis and purification |
| 04/05/2007 | US20070078605 Molecular docking technique for screening of combinatorial libraries |
| 04/05/2007 | US20070078186 Methods for treating transthyretin amyloid diseases |
| 04/05/2007 | US20070078079 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077431 Multi-layered macromolecules and methods for their use |
| 04/05/2007 | US20070077227 Preparing DNA binding protein comprising multiple zinc finger domains for use in identifying modulators of protein-nucleic acid recognition; gene expression inhibition |
| 04/05/2007 | US20070074972 Microfluidic assay devices and methods |
| 04/05/2007 | CA2623666A1 Dry platelet composition |
| 04/04/2007 | EP1770101A1 Antibodies against caspase-8, their preparation and use |
| 04/04/2007 | EP1770099A1 Method of producing a modified (poly)peptide |
| 04/04/2007 | EP1472286B1 Production process of recombinant placental growth factor |
| 04/04/2007 | EP1349866B1 Insulin purification using simulated moving bed technology |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942199A Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 04/04/2007 | CN1940059A Fermentation of FW523 series compound from marine single-cell FIMO2-523 |
| 04/04/2007 | CN1939585A Asymmetric porous adsorptive bead |
| 04/04/2007 | CN1308446C Earthworm plasmin multi-component preparation method from Eisenia foetida |
| 04/04/2007 | CN1308444C Method for purifying large quqntitics of fermentation liquid of gene recombined alpha galactosidase |
| 04/03/2007 | US7199248 Process |
| 04/03/2007 | US7199223 Water soluble polyoxyethylene glylcol polyvinylpyrrolidone, polyvinyl alcohol, polyoxazoline, and/or polyacryloylmorpholine, conjugated to antihemophilic factor |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7199099 Treating grampositive bacterial infections |
| 04/03/2007 | US7198949 Compositions and methods for altering the biodistribution of biological agents |
| 04/03/2007 | US7198931 Comprises mamamlian glyoxylase for modulating advanced glycation end products (AGEs) and diagnosis and treatment of vision defects and diabetes |
| 04/03/2007 | US7198930 Human protein kinase, phosphatase, and protease family members and uses thereof |
| 04/03/2007 | US7198929 Nucleotide sequences coding eukaryotic initiation factor-2 kinase for use in the identification of modulators which prevent and treat viral and liver disorders |
| 04/03/2007 | US7198890 by reacting the biological specimen with cysteine dioxygenase in the absence of a reducing agent, the free cysteine in the specimen is efficiently eliminated at first, and then by reacting it with a reducing agent, cysteines and homocysteines bound to proteins are liberated from the proteins |
| 04/03/2007 | CA2362193C Volatilizable solid phase supports for compound synthesis |
| 04/03/2007 | CA2259950C Radiometal-binding peptide analogues |
| 04/03/2007 | CA2165780C Selectively cleavable linkers based on iminodiacetic acid ester bonds |
| 04/03/2007 | CA2157530C Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 04/03/2007 | CA2094495C Methods for modifying and detecting the effects on the interaction of modified polypeptides and target substrates |
| 03/29/2007 | WO2007035864A2 Electrophoresis standards, methods and kits |
| 03/29/2007 | WO2007035283A1 Protein floculation using salts |
| 03/29/2007 | WO2007034812A1 Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier |
| 03/29/2007 | WO2007034198A1 Method for stabilisation of a protein solution by addition of hydroxyl radical quenchers and its sterilisation by ionising radiation |
| 03/29/2007 | WO2007012849A3 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP |
| 03/29/2007 | WO2006116717A3 Autologous somatic cells from peripheral blood and uses thereof |
| 03/29/2007 | WO2005074524A3 Modified human interferon polypeptides and their uses |
| 03/29/2007 | US20070072979 Dispersing agents in nanocomposites |
| 03/29/2007 | US20070072303 Method of chromatographic analysis of a protein solution |
| 03/29/2007 | US20070068813 Microfluidic device for electrically regulating the pH of a fluid therein and method of regulating the pH of a fluid in a microfluidic device using the same |
| 03/29/2007 | US20070068812 Microfluidic device for electrochemically regulating the ph of a fluid therein using semiconductor doped with impurity and method of regulating the ph of a fluid in a microfluidic device using the same |
| 03/29/2007 | DE102005046093A1 Reagent for reversible staining of proteins comprises a cationic detergent and a scandium chelate complex |
| 03/29/2007 | CA2623176A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | CA2620193A1 Separation of protein from impurities using salts |
| 03/28/2007 | EP1767629A2 Methods for the detection, analysis and isolation of nascent proteins |
| 03/28/2007 | EP1766028A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 03/28/2007 | EP1766011A1 Polypeptide ligands containing linkers |
| 03/28/2007 | EP1765853A2 O-linked glycosylation of peptides |
| 03/28/2007 | EP1765849A1 Process for protein isolation |
| 03/28/2007 | EP1765392A2 Apoptosis-inducing polypeptides |
| 03/28/2007 | EP1765362A2 Compositions and methods for treatment of neovascular diseases |
| 03/28/2007 | EP1554305B1 Prion protein-binding peptide sequences |
| 03/28/2007 | EP1393073A4 Methods for assembling protein microarrays |
| 03/28/2007 | EP1169349B1 Process for preparing gonadotropin compositions |
| 03/28/2007 | EP0773789B1 Use of MHC xenoantigen in the manufacture of a medicament for the treatment of cancer |
| 03/28/2007 | CN1307263C Reagent and method for saturation labelling of proteins |
| 03/28/2007 | CN1307199C Bone pattern generation protein 2 active peptide and its preparation method and application |
| 03/28/2007 | CN1307198C Separation and purification process of neurotoxin and cytotoxin of cobratoxin |
| 03/28/2007 | CN1307197C Heterosides peptide injection liquor for improving animal immunological function |
| 03/28/2007 | CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/27/2007 | US7196189 Comprises modified lovastatin regulatory proteins for use in treatment of hypercholesterolemia |
| 03/27/2007 | US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/27/2007 | US7195869 Comprises fusion proteins with green fluorescent protein to construct gene expression library; transcription factors; for treating tumor necrosis factor-related diseases |
| 03/27/2007 | US7195767 Method to detect IgE |
| 03/27/2007 | CA2275489C Oil bodies and associated proteins as affinity matrices |
| 03/27/2007 | CA2084552C Novel synthetic isohirudins with improved stability |
| 03/22/2007 | WO2007033383A2 Process for production of bivalirudin |
| 03/22/2007 | WO2007032363A1 Novel maleimide derivative |